The South African military will apply to run a clinical trial for the use of a drug known as Heberon to tackle COVID-19, ending a dispute over the illegal importation of the medicine by the South African National Defence Force, the health products regulator said.
The drug, a Cuban product that contains recombinant human interferon alpha-2b, has been touted as a potential treatment for the coronavirus, notes a BusinessTech report.
It has been used to treat various forms of cancer and leukaemia. The application will be examined by the South African Health Products Regulator, it said in a statement last week.
The dispute began when the regulator became aware of the arrival of the drug in the country in November.
Full BusinessTech report
See also MedicalBrief archives:Hawks and SAHPRA raid for ‘COVID cure’ blocked by SANDF
AG: SANDF already paid some of R260m for Cuban COVID ‘wonder cure’
Cuban anti-COVID drug cost R200m and used on only 1 patient
SANDF spends R200m on unapproved Cuban COVID drug